Why the study?
Recurrence commonly occurs after catheter ablation for ventricular arrhythmias due to inadequate lesion depth or inaccessible scar, prompting interest in stereotactic body radiotherapy.
Does stereotactic body radiotherapy improve treatment success in patients with refractory ventricular arrhythmias?
Does stereotactic body radiotherapy improve treatment success in patients with refractory ventricular arrhythmias?
Stereotactic body radiotherapy is a promising non-invasive treatment modality for refractory ventricular arrhythmias that overcomes the depth limitations of traditional catheter ablation.
Answers are grounded in this paper and cite their sources.
May offer a non-invasive option for refractory ventricular arrhythmias; leaves open the need for larger randomized trials.
Ventricular arrhythmias (VA) can be life-threatening arrhythmias that result in significant morbidity and mortality. Catheter ablation (CA) is an invasive treatment modality that can be effective in the treatment of VA where medications fail. Recurrence occurs commonly following CA due to an inability to deliver lesions of adequate depth to cauterise the electrical circuits that drive VA or reach areas of scar responsible for VA. Stereotactic body radiotherapy is a non-invasive treatment modality that allows volumetric delivery of energy to treat circuits that cannot be reached by CA. It overcomes the weaknesses of CA and has been successfully utilised in small clinical trials to treat refractory VA. This article summarises the current evidence for this novel treatment modality and the steps that will be required to bring it to the forefront of VA treatment.
No takes yet. Share an insight, caveat, or question.
Liulu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: